Melphalan
Showing 51 - 75 of 1,022
Bile Duct Cancer, Intrahepatic Cholangiocarcinoma Trial in Durham, Columbus, Memphis (Melphalan/HDS, Cisplatin and Gemcitabine)
Active, not recruiting
- Bile Duct Cancer
- Intrahepatic Cholangiocarcinoma
- Melphalan/HDS
- Cisplatin and Gemcitabine
-
Durham, North Carolina
- +2 more
Mar 23, 2022
Multiple Myeloma Trial in Torino (Velcade, Melphalan, Prednisone)
Recruiting
- Multiple Myeloma
- Velcade
- +5 more
-
Torino, TO, ItalyDipartimento di Biotecnologie Molecolari e Scienze per la Salute
May 25, 2022
Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell
Completed
- Hematologic Malignancies
- +7 more
- Melphalan
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 27, 2021
Renal Impairment, RRMM Trial in Czechia, Greece, Poland (Melphalan flufenamide (melflufen), Dexamethasone)
Terminated
- Renal Impairment
- RRMM
- Melphalan flufenamide (melflufen)
- Dexamethasone
-
Brno, Czechia
- +9 more
Feb 2, 2022
Retinoblastoma Trial in France (Melphalan or Melphalan + Topotecan, etoposide, carboplatin and vincristine, Carboplatin
Recruiting
- Retinoblastoma
- Melphalan or Melphalan + Topotecan
- +6 more
-
Saint-Denis, La RĂ©union, France
- +27 more
Nov 24, 2022
Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +6 more
- clofarabine
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in United States (Isolated Limb Infusion, Pembrolizumab,
Recruiting
- Sarcoma
- +3 more
- Isolated Limb Infusion
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Nov 21, 2022
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Trial in Duarte (drug, other,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Fludarabine
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Hematopoietic Stem Cell Transplantation Trial in Seoul (Melphalan)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Melphalan
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jun 23, 2021
Sickle Cell Disease Trial in Hackensack (Alemtuzumab, Fludarabine, Melphalan)
Active, not recruiting
- Sickle Cell Disease
- Alemtuzumab
- +3 more
-
Hackensack, New JerseyHackensack University Medical Center
Feb 4, 2022
Multiple Myeloma Trial in Atlanta (BeEAM)
Completed
- Multiple Myeloma
-
Atlanta, GeorgiaBlood and Marrow Transplant Group of Georgia
Oct 19, 2022
Multiple Myeloma, Olfactivo-gustatory Disorder, Lymphoma Trial in Montpellier (Multifactorial sensory rehabilitation workshops,
Recruiting
- Multiple Myeloma
- +2 more
- Multifactorial sensory rehabilitation workshops
- +2 more
-
Montpellier, FranceHematology Department, University Hospital Center
Dec 31, 2021
Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,
Active, not recruiting
- Autologous Hematopoietic Stem Cell Transplant Recipient
- +4 more
- bortezomib
- +7 more
-
Duarte, CaliforniaCity of Hope
Mar 17, 2022
Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,
Completed
- Anaplastic Oligoastrocytoma
- +3 more
- Carboplatin
- +7 more
-
Minneapolis, Minnesota
- +1 more
Mar 11, 2022
Uveal Melanoma, Metastatic Trial in Leiden (Ipilimumab and nivolumab, Melphalan chemosaturation via percutaneous hepatic
Recruiting
- Uveal Melanoma, Metastatic
- Ipilimumab and nivolumab
- Melphalan chemosaturation via percutaneous hepatic perfusion
-
Leiden, Zuid-Holland, NetherlandsLeiden University Medical Center
Apr 8, 2022
GVHD, Leukemia, Lymphoma Trial in Duarte (biological, drug, procedure, radiation, other)
Active, not recruiting
- Graft Versus Host Disease
- +2 more
- rituximab
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid
Recruiting
- Previously Treated Myelodysplastic Syndrome
- +3 more
- Fludarabine Phosphate
- +9 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jan 7, 2022
Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (C-BEAM Regimen, BEAM Regimen)
Recruiting
- Newly Diagnosed Peripheral T-cell Lymphoma
- C-BEAM Regimen
- BEAM Regimen
-
Nanjing, Jiangsu, ChinaHematological Department, People's Hospital of Jiangsu Province
Jun 27, 2023
Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)
Not yet recruiting
- Autologous Stem Cell Transplantation
- Conditioning
- modified BEAM
- BEAM
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023
Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,
Active, not recruiting
- Acute Leukemia
- +4 more
- Fludarabine
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan,
Not yet recruiting
- Metastatic Uveal Melanoma
- Metastatic Cutaneous Melanoma
- Autologous Tumor Infiltrating Lymphocytes
- +2 more
- (no location specified)
Oct 14, 2022